Elvitegravir

ATC J05AR09 · 9 markets · 30 records

Elvitegravir 9 markets · 30 records Forms

GB 6 records · 3 strengths

150 mgtabletGenvoya+2Stribild、Vitekta 85mg tablets also in AU·US·CA +2
90 mgtabletGenvoya
85 mgtabletVitekta 85mg tablets

AU 5 records · 2 strengths

150 mgtabletGenvoya+2GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets、STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle also in GB·US·CA +2 unknown

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Genvoya ×5Stribild ×5

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 2 records · 1 strengths

150 mgtabletGenvoya+1Stribild also in GB·AU·CA +2

CA 2 records · 1 strengths

150 mgtabletGenvoya+1Stribild also in GB·AU·US +2

ES 2 records · 1 strengths

150 mgtabletGenvoya+1Stribild also in GB·AU·US +2

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Genvoya ×5Stribild ×5

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 2 records · 1 strengths

150 mgtabletGENVOYA 150 mg/150 mg/200 mg/10 mg, comprimé pelliculé+1STRIBILD 150 mg/150 mg/200 mg/245 mg, comprimé pelliculé also in GB·AU·US +2

TW 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Genvoya ×5捷扶康膜衣錠 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	TW	EU	FR
150 mg tablet	Genvoya Stribild	Genvoya Stribild Vitekta 85mg tablets	Genvoya Stribild	Genvoya GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle	Genvoya Stribild	not recorded	not recorded	GENVOYA 150 mg/150 mg/200 mg/10 mg, comprimé pelliculé STRIBILD 150 mg/150 mg/200 mg/245 mg, comprimé pelliculé
90 mg tablet	not recorded	Genvoya	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
85 mg tablet	not recorded	Vitekta 85mg tablets	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Genvoya Stribild	not recorded	not recorded	Genvoya Stribild	not recorded
not disclosed tablet	not recorded	not recorded	not recorded	not recorded	not recorded	Genvoya 捷扶康膜衣錠	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 TW 有记录（未在本表显示）。另有 1 個規格/劑型僅在 TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.